|
17 Dec 2010 |
RXi Pharmaceuticals Nominates Dermal Anti-Scarring RNAi Product Candidate to Advance into Development
|
|
16 Dec 2010 |
Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
|
|
15 Dec 2010 |
Evotec Announces Metabolic Disease Alliance With MedImmune
|
|
13 Dec 2010 |
EGEN Announces that Phase II Clinical Trial for Advanced Ovarian Cancer is Open for Enrollment
|
|
10 Dec 2010 |
BioVex Commences OncoVEXGM-CSF Phase 3 Trial in Head and Neck Cancer
|
|
10 Dec 2010 |
Spinal Cord Injury Patient Treated With Non-Matched Adult Stem Cells
|
|
08 Dec 2010 |
MESOBLAST AND CEPHALON ENTER INTO STRATEGIC ALLIANCE TO COMMERCIALIZE NOVEL THERAPEUTIC PRODUCTS FOR REGENERATIVE MEDICINE
|
|
07 Dec 2010 |
Cytori Therapeutics Enters Strategic Equity Deal With Astellas Pharma; To Sell $10 Million in Equity at $7.00 per Share
|
|
07 Dec 2010 |
StemCells, Inc. Receives Authorization to Conduct World's First Neural Stem Cell Trial in Spinal Cord Injury
|
